Cord Blood Levels of IL-31 and CCL17 and cutaneous markers may predict Atopic Dermatitis Risk in Infants: JAMA Medha Baranwal18 Sept 2024 9:15 PM ISTItaly: A recent observational study published in JAMA Dermatology has shed light on the potential for cord blood serum levels of specific cytokines to...
Metformin Emerges as a Promising Therapy for CCCA, Addressing Fibrosis and Hair Loss: JAMA Medha Baranwal16 Sept 2024 9:30 PM ISTUSA: Recent findings from a case series study suggest that low-dose oral metformin, commonly used in diabetes management, may offer new hope for...
Home-Based UV-B Phototherapy as Effective as Office-Based Treatment for Psoriasis, LITE Trial Reveals Medha Baranwal3 Sept 2024 1:00 AM ISTUSA: A recent randomized clinical trial known as the LITE trial has revealed that home-based phototherapy is as effective as office-based phototherapy...
Zasocitinib therapy highly efficacious for treatment of severe plaque psoriasis: JAMA Jacinthlyn Sylvia2 Sept 2024 2:00 AM ISTA recent study published in the Journal of American Medical Association revealed that Zasocitinib could be a breakthrough in the treatment of moderate...
Quitting smoking and maintaining smoking-free status may reduce risk of hidradenitis suppurativa onset: JAMA Dr Riya Dave26 Aug 2024 6:15 AM ISTResearchers found that smoking cessation and continuous nonsmoking were associated with a significantly lower incidence of developing hidradenitis...
Cendakimab effective, safe, and well-tolerated in patients with moderate to severe atopic dermatitis: JAMA Dr Riya Dave13 Aug 2024 8:30 AM ISTResearchers have found that cendakimab, an interleukin-13 (IL-13) targeting monoclonal antibody, significantly reduces the severity of atopic...
Cendakimab Shows Efficacy and Safety in Treating Moderate to Severe Atopic Dermatitis: Results from Clinical Trial Medha Baranwal2 Aug 2024 8:30 PM ISTUSA: In a phase 2 randomized clinical trial of 221 patients with moderate to severe atopic dermatitis (AD), treatment with cendakimab, an...
Poor neighbourhood may predict severe skin lesions in discoid lupus erythematosus: JAMA Dr Riya Dave31 July 2024 9:45 PM ISTResearchers have found that socioeconomic and behavioral factors are of prime importance in the severity of discoid lupus erythematosus among the...
Dupilumab effective in adults with moderate to severe atopic dermatitis: JAMA Jacinthlyn Sylvia19 July 2024 2:30 AM ISTA recent trial by Lisa Beck and team found that continued long-term dupilumab therapy was safe and effective for individuals with moderate to severe...
Isotretinoin Shows Promise for Acne in Transgender and Gender-Diverse Individuals on Masculinizing Hormone Therapy: JAMA Medha Baranwal8 July 2024 10:30 AM ISTUSA: In a groundbreaking study published in the JAMA Dermatology, researchers have shed light on the efficacy and safety of isotretinoin treatment for...
Revolutionizing infant dermatology: Weekly pulsed dye laser treatments erase birthmarks safely and swiftly, study finds Medha Baranwal5 July 2024 9:30 PM ISTNew York: In a groundbreaking development for pediatric dermatology, weekly pulsed dye laser treatments yield promising results in managing infants'...
Worst Itch Numeric Rating Scale may Revolutionize Prurigo Nodularis Treatment Evaluation: JAMA Medha Baranwal2 July 2024 6:30 AM ISTUSA: Prurigo Nodularis (PN), a debilitating skin condition characterized by intensely itchy nodules, poses a significant challenge to patients and...
